Everything about Tyrosinase-IN-12
MI-CP151 was a phase 1b randomised, double-blind, placebo managed, dose-escalation, multicentre research To judge multiple intravenous doses of sifalimumab, in adult patients with dermatomyositis or polymyositis (NCT00533091). Most important trial goals have been to evaluate the security and tolerability of sifalimumab in dermatomyositis or polymyo